Ipca Laboratories

Update in progress

IPCALAB.NS (NSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Ipca Laboratories Limited is an integrated pharmaceutical company that develops and manufactures formulations and active pharmaceutical ingredients (APIs). It serves India, Europe, Africa, the Americas, Asia, the CIS and Australasia, and exports worldwide. Ipca offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD and anthelmintic areas, and markets generic and branded formulations across many therapeutic domains, including cardiology, diabetes, dermatology, and neurology. Incorporated in 1949 and based in Mumbai.

Company score

Sentiment: 0.05; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.03; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: -0.16; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: -0.02; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.01; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive